Thanks!
FLUT numbers/outlook were solid. EPS was $2.61 vs $1.70 estimated. Revenue of $3.61B was 7% better than expected. Guidance was raised and it continues to win US market share. We have more comments posted today in the Q&A. SPB has a loss of 20c vs estimates of -10c; revenue of $422.9M missed estimates of $465.9M. EBITDA of $43.4M missed estimates of $46.8M. EBITDA rose 47%; revenue fell 2.3%. Guidance was largely maintained, with 5% EBITDA growth expectations. Nothing too excitng here and investors may not like the 'miss'. WELL has not yet reported at the time of this question.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in FLUT.